Manidipine Arrow (Manidipine Dihydrochloride)

Manidipine selectively blocks L‑type calcium channels in the smooth muscle of blood vessels. This inhibition prevents calcium‑induced contraction, causing the vessels to relax and widen (vasodilation). The resulting decrease in peripheral resistance leads to a reduction in arterial pressure without significantly affecting heart contractility.

The appropriate dose of Manidipine Arrow is determined by the prescribing healthcare professional based on the individual’s clinical condition, response to therapy, and any concomitant medications. Patients should follow the prescriber’s instructions and not alter the dose without medical guidance.

The safety of manidipine in pregnancy and lactation has not been established, and the pregnancy category is listed as unknown. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Manidipine belongs to the dihydropyridine calcium‑channel blocker class, which primarily causes arterial vasodilation. Compared with ACE inhibitors or ARBs, it has a lower incidence of cough but may cause more peripheral edema. Its once‑daily dosing and selective vascular action make it a useful alternative for patients who cannot tolerate other classes.

Manidipine Arrow tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children. No refrigeration is required.

Manidipine Arrow is taken orally, usually once daily with or without food, as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew it unless specifically instructed by a healthcare professional.

Serious adverse events, although rare, include severe hypotension, myocardial infarction, hepatic dysfunction, allergic reactions such as rash or angioedema, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms like fainting, chest pain, severe dizziness, or swelling of the face or throat.

Manidipine Arrow is contraindicated in patients with known severe hypotension, cardiogenic shock, or a history of allergic reactions to calcium‑channel blockers. Caution is advised for individuals with significant liver impairment, elderly patients, or those taking interacting medications. The prescriber should evaluate each patient’s medical history before initiating therapy.